TITLE

Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma

AUTHOR(S)
Dietrich, S; Weidle, J; Rieger, M; Meissner, J; Radujkovic, A; Ho, A D; Dreger, P; Witzens-Harig, M
PUB. DATE
March 2014
SOURCE
Leukemia (08876924);Mar2014, Vol. 28 Issue 3, p708
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a research study which examined the improvement of prognosis in patients with mantle cell lymphoma (MCL) with rituximab maintenance therapy. A complete response (CR) before autologous stem cell transplantation (autoSCT) was obtained by 27 patients. The study showed that rituximab maintenance therapy was related to better progression-free survival (PFS), but not overall survival (OS) by univariate analysis.
ACCESSION #
94762950

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics